跳至主要内容
临床试验/NCT01855529
NCT01855529已完成2 期

ROPI Study: Evaluation of the Interest of Ropivacaine Streaming in Postoperative Pain After Mastectomy.

Centre Jean Perrin1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2013年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
Daily consumption of morphine during the first 48 postoperative hours.

研究概览

简要总结

After surgery for breast cancer, the prevalence of chronic pain is estimated between 20 and 68%. They begin after surgery and may persist until more than 6 months. They respond poorly to opioid analgesics impair the quality of life.

Among the different postoperative analgesic techniques used, the use of a local anesthetic infiltration continues catheter has advantages including improving the quality of analgesia, with a significant decrease in average of VAS (scale visual Analogue), a decrease in morphine consumption, improving the quality of life of patients.

Our study aims to evaluate the effectiveness of a continuous local anesthetic infiltration in the control of postoperative pain after mastectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age> 18 years
  • ASA I-II, WHO 0-1
  • mastectomy alone, mastectomy + GGS + mastectomy CA
  • No previous history of chronic pain requiring regular intake of analgesics or long-term
  • Failure to take opioids within 30 days before surgery

排除标准

  • Long-term treatment analgesic or taking opioids within 30 days before surgery
  • Concurrent treatment with a drug test, participation in another therapeutic clinical trial within <30 days
  • proven allergy to local anesthetics of the amide
  • Skin Inflammation
  • Sepsis local
  • Kidney failure, liver failure, severe or poorly controlled diabetes
  • Inability to respond to the assessment of pain using a visual analogue scale (VAS) or a numerical scale (FR).
  • mastectomy with immediate breast reconstruction

研究组 & 干预措施

Ropivacaine arm

Experimental

Ropivacaïne 2 mg/ml 10ml/h

干预措施: Ropivacaine in one arm and placebo (NaCl) in the other arm (Drug)

NaCl arm

Placebo Comparator

NaCl 0,9% 250ml 10 ml/h

干预措施: Ropivacaine in one arm and placebo (NaCl) in the other arm (Drug)

结局指标

主要结局

Daily consumption of morphine during the first 48 postoperative hours.

时间窗: during the first 48 postoperative hours

次要结局

  • Assessment every 4 hours by the IDE that will support the patient during the first 48 hours, then every analgesic taken: • The intensity of pain, VAS or EN(During the first 48 h after surgery)
  • Assessment every 4 hours by the IDE that will support the patient during the first 48 hours, then every analgesic taken: Possible side effects The most common expected morphine: nausea, vomiting, pruritus, acute urine retention.(during the 48h after the surgery)
  • Assessment every 4 hours by the IDE that will support the patient during the first 48 hours, then every analgesic taken: • The site of pain(during the first 48h after the surgery)
  • Assessment every 4 hours by the IDE that will support the patient during the first 48 hours, then every analgesic taken: Determination of Ropivacaine plasma at T0+ 24 h, T0+48h(during 48h after the surgery)
  • Determination of Ropivacaine plasma (analytical blank: T0)(T0, the day of surgery)
  • Assessment every 4 hours by the IDE that will support the patient during the first 48 hours, then every analgesic taken: A potential analgesics administered(during the first 48h after the surgery)
  • Assessment every 4 hours by the IDE that will support the patient during the first 48 hours, then every analgesic taken: Constant: pulse, blood pressure, tympanic temperature, respiratory rate, sedation (0: awake, 1: sleepy, 2 comatose).(during 48h after the surgery)
  • Assessment every 4 hours by the IDE that will support the patient during the first 48 hours, then every analgesic taken: Possible side effects of ropivacaine expected the most common: nausea, vomiting, headache, dizziness, paresthesias.(during 48 hours after the surgery)
  • Assessment every 4 hours by the IDE that will support the patient during the first 48 hours, then every analgesic taken: Condition of dressing • On any abnormality at the site of administration: local redness, pain, skin warmth, pruritus.(during the 48h after the surgery)

研究者

发起方
Centre Jean Perrin
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验